Case ID: f-appx_596/html/0922-01.html
Source: Caselaw Access Project
Author: {"author": "PER CURIAM.", "license": "Public Domain", "url": "https://static.case.law/"}
Date Created: 2024-08-24T03:29:51.129683

ROXANE LABORATORIES, INC., Plaintiff-Appellant v. CAMBER PHARMACEUTICALS INC., Invagen Pharmaceuticals Inc., Defendants-Appellees.
    No. 2014-1803.
    United States Court of Appeals, Federal Circuit.
    March 12, 2015.
    Kenneth G. Schuler, Latham & Watkins LLP, Chicago, IL, argued for plaintiff-appellant. Also represented by Marc Nathan Zubick; Alexander Enrico Long, San Diego, CA; Gregory Sobolski, San Francisco, CA; Robert J. Gajarsa, Washington, DC.
    Robert S. Silver, Caesar, Rivise, Bernstein, Cohen & Pokotilow, Ltd., Philadelphia, PA, argued for defendants-appellees. Also represented by James J. Kozuch, Salvatore Guerriero, Pei-Ru Wey.
    LOURIE, REYNA, and CHEN, Circuit Judges.
   JUDGMENT

PER CURIAM.

This Cause having been heard and considered, it is

Ordered and Adjudged:

AFFIRMED. See Fed. Cir. R. 36.